LITTLE FALLS, N.J.,
June 27, 2018 /PRNewswire/ --
Cantel Medical Corp. (NYSE: CMD) today announced that its
Board of Directors authorized a regular semiannual cash dividend of
$0.085 per outstanding share of the
Company's Common Stock. The dividend is payable on July 31, 2018 to shareholders of record at the
close of business on July 17,
2018.
About Cantel Medical
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, dialysate concentrates, hollow
fiber membrane filtration and separation products. Additionally, we
provide technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
View original
content:http://www.prnewswire.com/news-releases/cantel-medical-board-of-directors-authorizes-regular-semiannual-dividend-300673183.html
SOURCE Cantel Medical Corp.